Hieronder vindt u een overzicht van de proefschriften van de afdeling die in de afgelopen jaren verschenen zijn:

November 2019:

Pharmacogenetics and cost-effectiveness of systemic treatment in soft tissue sarcoma
Michiel Verboom

June 2019:

Personalised medicine of fluoropyrimidines using DPYD pharmacogenetics
Carin Lunenburg

November 2018:

Improving acceptance of pharmacogenetic testing in patient care
Paul Bank

September 2018:

Individualized dosing of fluoropyrimidines by genotyping and phenotyping of dihydropyrimidine dehydrogenase
Linda Henricks

Mei 2018:

Optimization of sunitinib treatment in metastatic renal cell carcinoma: pharmacogenetic evidence and challenges
Liu, X

Januari 2018:

Translation of academic medicinal products towards clinical practice
Sofieke de Wilde 

September 2017:

Pharmacogenetics of sunitinib in metastatic renal cell carcinoma

Meta Diekstra cum laude

Juni 2017:

Pharmaceutical pictograms for low-literate medication users
Mara van Beusekom

December 2016:

Pharmacogenetics of osteosarcoma treatment
Hanneke Vos

November 2016:

DPD screening to prevent toxicity in fluoropyrimidine treated patients
Staveren, M.C. van

January 2016:

The role of clinical pharmacology and pharmacogenetics in electroconvulsive therapy: from safety to efficacy
Hooman Mirzakhani

Oktober 2015:

Dose optimization of oral targeted therapies in oncology
Djoeke de Wit

Oktober 2015:

Phenotyping in oncology
Frans Luitzen Opdam

Juli 2015:

proefschriftomslag Lisanne KrensRefining EGFR-monoclonal antibody treatment in colorectal cancer
Lisanne Krens

Juni 2015:

proefschrift omslag Lieke van HuisPharmacogenetics of capecitabine and oxaliplatin in treatment of advanced colorectal cancer
Lieke van Huis-Tanja

Maart 2015:

cover thesis Melanie HagleitnerThe role of pharmacogenetics in Osteosarcoma
Melanie Margaretha Hagleitner

November 2014:

Optimizing immunosuppression with mTOR inhibitors in renal transplant recipients
Dirk Jan Moes

Oktober 2014:

Cover proefschrift Rodney RosarioParticulate based vaccines for cancer immunotherapy
Rodney Alexander Rosalia

proefschriftomslag Marloes ten BrinkSeptember 2014:

Individualized therapeutics in allogenic stem cell transplantation 
Marloes ten Brink

September 2014:

Exploring novel formulations and new classes of anticancer drugs in solid tumors
Marije Slingerland

Mei 2014:

Clinical rules in hospital pharmacy practice to prevent adverse drug events
Mirjam Kristien Rommers

Oktober 2013:

Tamoxifen metabolism and pharmacogenetics in breast cancer
Vincent Dezentjé

Januari 2012:

Pharmacogenetics of Antiemetics in Indonesian Cancer Patients
Dyah Aryani Perwitasari

December 2011:

Translating pharmacogenetics to primary care
Jesse Swen

Juni 2011:

Jan Pander
Pharmacogenetics of advanced colorectal cancer treatment

April 2011:

Individualized dosing of calcineurin inhibitors on renal transplantation
Rogier Press

thesis Maarten ZandvlietMaart 2011:

Adoptive immunotherapy for viral infections after allogeneic stem cell transplantation
Maarten L. Zandvliet

thesis E.R. KoomenSeptember 2010:

Drug effects on melanoma.
E.R. Koomen

thesis P.H. van ErpDecember 2009:

Clinical Pharmacology of the Tyrosine Kinase Inhibitors Imatinib and Sunitinib.
P.H. (Petronella Huberta) van Erp

thesis Wouter KooloosDecember 2009:

Potential role of pharmacogenetics for optimalization of drug therapy in rheumatoid arthritis.
W.M. Kooloos (Wouter Michiel)

November 2009:

Targeted therapy in oncology: mechanisms and toxicity
N. (Neeltje) Steeghs

thesis D.M. Kweekel

Mei 2009:

Pharmacogenetics of Irinotecan and Oxaliplatin in Advanced Colorectal Cancer
D.M. (Dina Maria) Kweekel

thesis Ali Vahidnia

Februari 2008:

Studies into the mechanisms of arsenic-induced neurotoxicity.
Ali Vahidnia

Oktober 2007:

Pharmacogenetics of methotrexate in patients with Rheumatoid Arthritis.
J.A.M. (Judith Anne-Marie) Wessels

September 2007:

The cytotoxic drug Cyclo-Pentenyl Cytosine: from manufacturing to anti-tumor activity and (cardio)toxicity.
K.J.M. (Kirsten Johanna Maria) Schimmel

thesis A. de JongJanuari 2005:

T cell immunity against early antigens of human papillomavirus type 16.
A. (Annemieke) de Jong